(PharmaNewsWire.Com, March 09, 2018 ) The report “Global companion diagnostics market is expected to reach USD 6.53 Billion by the year 2024, at a CAGR of 26.3% during forecast period. The Oncology is primarily attributed to the growing incidence of cancer that enhanced the focus on cancer research and also widens the role of companion diagnostics in the field. Based on the end-user, the pharmaceutical and biopharmaceutical companies segment reckons for the largest share of the market. developments in predictive biomarkers play a key role in the successful profit-oriented of companion diagnostics. There are two dominant therapy areas: Oncology and neurology. There is an increase in growth strategies among vendors.
Companion Diagnostics are an important aspect of the personalized treatment approach and are crucial for forecasting the therapeutic response to a particular drug. Companion Diagnostics are in-Vitro diagnostics that produce knowledge about therapeutic responses of patients for a specific treatment. Companion Diagnostics is used to identify suitable patients to whom specific drugs can be managed and it monitors the prognosis of the effects of the drugs on a disease.
Reasons To Buy This Report This report contains the in-depth analysis on the market and the estimations are done using volume and value data are further validated on three approaches including bottom-up, top-down and from top companies revenues to conclude the market estimations precisely and accurately considering all the parameters and market dynamics.
Key pointers in the report include: • Competitive landscape & market analysis is included in the report to understand the key companies’ position and Porter's Analysis & PESTLE analysis to perform to analyze the impact of drivers, restraints, challenges and constraints on the market during the next five years. • Team of analysts have analyzed and listed out the key drivers, constraints, challenges and emerging opportunities in all the industry verticals which will specify the emerging scope for the market in end user industries. • Industry value chain analysis is provided in the report to identify the key stakeholders and prominent players at each stage of the company along with the value addition at each stage of the value chain. • Complete analysis including global and regional trends, technological developments, and new product innovations are included in the report specific to each and every segment of the market. • A complete 360 degree analysis is provided in the report on key companies’ product portfolio, business portfolio, developmental strategies, and key developments from the companies in the historical period. • Advanced customizations on countries, specific applications in end user industries, product based customizations will be provided based on the request. • All the collected data is further validated and verified using surveys, interviews and interactions with industrial experts.
Companion Diagnostics Market Top Players • Abbott Laboratories • Agilent Technologies, Inc. • Biomérieux • Biogenex Laboratories • Danaher Corporation • Roche Diagnostics • Thermo Fisher Scientific, Inc. • GE Healthcare • R-Biopharm AG • Myriad Genetics, Inc. • Qiagen N.V. • Cypher Genomics • Flagship Biosciences • Ignyta, Inc. • Madison Vaccines, Inc. • Ventana Medical Systems, Inc. •
About us Envision Inteligence is the Main Supplier of Market Analysis Reviews, Customized Consulting Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time, in a format which assists an clever and knowledgeable resolution making course of!
Contact Us Envision inteligence Sales@envisioninteligence.com contact@envisioninteligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
